CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bio Synectics, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bio Synectics, Inc.
708, Byucksan Digital Valley II
184, Gasan digital 2-ro, Geumcheon-gu
Phone: +82 221131285p:+82 221131285 SEOUL, 08501  South Korea Fax: +82 221131284f:+82 221131284

This company is no longer actively traded on any major stock exchange.

Business Summary
Bio-Synectics, Inc. is a Korea-based company principally engaged in the development of nanoparticle technology and drug delivery systems. The Company’s products include HydroCurcumin and HydroCoQ10. HydroCurcumin is a material that can overcome curcumin’s poor solubility. HydroCoQ10 is a material that can overcome poor solubility of Coenzyme Q10 (CoQ10). The Company is also engaged in the development of function food and cosmetic materials. The Company distributes its products within domestic market and to overseas markets.
(Source: PRESS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202212/31/2022Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

General Information
Number of Employees: 7 (As of 12/31/2022)
Outstanding Shares: 2,650,890 (As of 12/31/2022)
Shareholders: 219
Stock Exchange: KON
Fax Number: +82 221131284
Email Address: info@bio-synectics.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024